Characterisation of the neutrophilic asthma phenotype over time.

C. Blouin (Quebec, Canada), K. Godbout (Quebec, Canada), M. Boulay (Quebec, Canada), A. Bhalla (Hamilton, Canada), P. Nair (Hamilton, Canada), L. Boulet (Quebec, Canada), A. Côté (Quebec, Canada)

Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Session: Phenotypes of obstructive diseases
Session type: E-poster session
Number: 1242
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Blouin (Quebec, Canada), K. Godbout (Quebec, Canada), M. Boulay (Quebec, Canada), A. Bhalla (Hamilton, Canada), P. Nair (Hamilton, Canada), L. Boulet (Quebec, Canada), A. Côté (Quebec, Canada). Characterisation of the neutrophilic asthma phenotype over time.. 1242

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


Characteristics, definition and phenotypes of severe asthma
Source: Eur Respir Mon 2011; 51: 50-58
Year: 2011


Evidence of a distinct phenotype of adult onset asthma characterized by an airway neutrophilia and poor response to inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001

The role of neutrophilic inflammation in asthma of different severity
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002

Increased sputum B cells in severe eosinophilic asthma: a local auto-inflammatory process
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018


A 4-week model of allergic airways inflammation that exhibits the 3 salient features of asthma.
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Evolution of asthma in relation to the bronchial inflammatory phenotype: a follow-up study
Source: International Congress 2018 – Asthma analysis
Year: 2018




Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005

Opioid-neurotensin hybrid influences pulmonary inflammatory process in murine model of non-atopic asthma.
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Neutrophilic asthma features increased airway classical monocytes
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017

Neutrophilic asthma: a distinct phenotype?
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012

Clinical and inflammatory determinants of (the course of) bronchial hyperresponsiveness in COPD
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

Features of FeNO-high asthma phenotype
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Stability of the eosinophilic phenotype in stable and exacerbated COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018



Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 217s
Year: 2006

Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013